A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
Yang Yang(The University of Texas at San Antonio Health Science Center), Daohong Zhou(The University of Texas at San Antonio Health Science Center)
Cited by 37
Related Papers
Pivotal Role for Acidic Sphingomyelinase in Cerebral Ischemia-Induced Ceramide and Cytokine Production, and Neuronal Apoptosis
|Journal of Molecular Neuroscience|2000|209
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
|Frontiers in Cell and Developmental Biology|2022|147
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
|Nature Communications|2021|145
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
|Journal of Hematology & Oncology|2020|129